Article info
Editorial
Periprocedural type IVa myocardial infarction and the importance of platelet inhibition
- Correspondence to Professor David E Newby, BHF/University Centre for Cardiovascular Science, Chancellor's Building, Royal Infirmary, Little France, Edinburgh EH16 4SB, UK; d.e.newby.@ed.ac.uk
Citation
Periprocedural type IVa myocardial infarction and the importance of platelet inhibition
Publication history
- First published April 16, 2013.
Online issue publication
August 02, 2013
Article Versions
- Previous version (16 April 2013).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions